Expanding human healthspan

Status.

Listed in the programme table at the selling stage. Commercial availability is not an evidence grade.

Composition and official label.

Ingredient names currently listed on this website: Creatine, glycine and maca.

The complete official label has not been supplied for this review. Ingredient quantities, excipients, allergens, recommended daily dose and market-specific warnings remain to be verified. This is not a complete label transcription.

Available evidence: preclinical.

The website describes research in preclinical in vivo models. Product-specific protocols, comparators, sample sizes, doses, endpoints, effect sizes and peer-reviewed references are not documented in the material reviewed.

Evidence level: not gradable from the public documentation available here. Platform research totals are not a product-specific efficacy or safety result.

Available evidence: humans.

No completed product-specific human study is documented in the reviewed material. This does not establish that no such study exists. No human efficacy or safety conclusion is made.

Safety and precautions.

Do not exceed the recommended daily dose. Food supplements should not be used as a substitute for a varied and balanced diet and a healthy lifestyle. Keep out of reach of young children.

Refer to the current packaging and consult a qualified health professional. Product-specific contraindications, interactions, age restrictions and pregnancy or breastfeeding warnings require verification against the official label.

Limitations and medical advice.

Preclinical observations do not establish clinical benefit. Ingredients alone do not demonstrate the effect or safety of a finished formulation. This information does not replace medical advice, diagnosis or treatment.

Questions and answers.

What is BLUFEM?

BLUFEM is listed in the VivoXpand shop as a food supplement and shown in the programme table at the selling stage. That commercial stage does not establish clinical efficacy or safety. The product dossier distinguishes the ingredients already listed on this website from a complete verified label and separates preclinical research from evidence in humans.

Is the composition shown here the complete official label?

No. The BLUFEM dossier repeats the ingredient names already listed in the approved shop, but a complete official label has not been provided for this review. Ingredient amounts, excipients, allergens, daily dose and market-specific warnings require verification against the current packaging. The summary should not be treated as a complete composition or as dosing instructions.

What evidence is available for BLUFEM?

The website describes a preclinical in vivo research platform, but the material reviewed does not contain a complete product-specific study dossier for BLUFEM. Protocols, controls, sample sizes, quantitative outcomes and publications need verification. Platform research totals cannot substitute for formulation-specific evidence, and they do not establish clinical benefit in people who take the supplement.

Does preclinical assessment prove an effect in humans?

No. Findings in a mouse model apply to the model, formulation and study conditions assessed. They cannot automatically be transferred to a human dose, population or outcome. For BLUFEM, completed product-specific human studies are not documented in the reviewed material. Any claim about effects in people requires its own verified evidence and applicable regulatory review.

What precautions should I consider?

For BLUFEM, consult the current packaging and a qualified health professional for advice relevant to your situation. Do not exceed the recommended daily dose. Food supplements should not replace a varied, balanced diet and healthy lifestyle, and must be kept out of reach of young children. Product-specific contraindications, interactions, age restrictions and pregnancy warnings require label verification.

Does this information replace medical advice?

No. This product information does not replace medical advice, diagnosis or treatment. If you are considering BLUFEM, particularly alongside medicines or with an existing health condition, discuss the verified label with a qualified health professional. The public dossier describes the available documentation and its limitations; it does not establish an individual recommendation or a guarantee of safety.